Results 231 to 240 of about 8,330,269 (304)

Coronavirus disease 2019 (COVID-19) for global faith and community leaders [Urdu]

open access: yes
Coronavirus disease 2019 (COVID-19) for global faith and community leaders [Urdu]Publication date from document properties.COVID-19-global-faith-leaders_urdu.pdf2020https://www.cdc.gov/coronavirus/2019-ncov/downloads/COVID-19-global-faith-leaders_urdu ...

core  

What is the impact of sports‐related gambling advertising on gambling behaviour? A systematic review

open access: yesAddiction, Volume 120, Issue 4, Page 589-607, April 2025.
Abstract Background and Aims Gambling is a public health issue and widespread advertising of gambling products may contribute to gambling harms. Sports‐related gambling advertising includes advertising around sports games or for sports betting products.
Ellen McGrane   +5 more
wiley   +1 more source

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) units

open access: yesAddiction, EarlyView.
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne   +9 more
wiley   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

open access: yesAddiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark   +8 more
wiley   +1 more source

Craving and personal functioning as mediators of extended‐release buprenorphine efficacy: A four‐way decomposition analysis from a randomised trial

open access: yesAddiction, EarlyView.
Abstract Aims To investigate whether the treatment effect of extended‐release buprenorphine (BUP‐XR) on opioid‐free days in opioid use disorder (OUD) is mediated by reductions in opioid craving and improvements in personal functioning. Design and setting Exploratory causal mediation analysis using VanderWeele's four‐way decomposition framework in a 24 ...
John Marsden   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy